Update: 14.01.2024
Last week: 52 week 2024 (23.12.2024 - 29.12.2024)
Last full month: November 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 7 983 | -11.5% | 12.4% | -1.4 | 15 457 482 | -11.6% | 8.7% | -1.1 | -1.8% |
| MoM | 44 632 | -3.6% | 13.3% | -0.2 | 78 965 673 | 0.5% | 8.9% | 0.2 | -2.0% |
| YTD | 421 445 | 23.6% | 12.3% | 3.2 | 839 087 279 | 27.7% | 9.3% | 1.6 | -8.2% |
| MAT | 421 445 | 23.6% | 12.3% | 3.2 | 839 087 279 | 27.7% | 9.3% | 1.6 | -8.2% |
| BRAINMAX | |||||||||
| WoW | 2 245 | -3.1% | 100.0% | 0 | 7 471 863 | -6.3% | 100.0% | 0 | -3.1% |
| MoM | 11 703 | 2.1% | 100.0% | 0 | 38 888 035 | -0.2% | 100.0% | 0 | 2.1% |
| YTD | 82 666 | 77.2% | 100.0% | 0 | 286 721 041 | 78.1% | 100.0% | 0 | 77.2% |
| MAT | 82 666 | 77.2% | 100.0% | 0 | 286 721 041 | 78.1% | 100.0% | 0 | 77.2% |
| GOLDLINE PLUS | |||||||||
| WoW | 14 116 | 5.9% | 47.3% | 0.8 | 45 210 908 | 9.2% | 38.7% | 1.2 | 4.1% |
| MoM | 62 745 | -4.1% | 47.4% | 1.3 | 195 756 051 | -3.4% | 38.7% | 0.9 | -6.7% |
| YTD | 829 100 | -4.6% | 45.4% | 0.5 | 2 602 788 887 | -3.3% | 37.2% | -2.5 | -5.7% |
| MAT | 829 100 | -4.6% | 45.4% | 0.5 | 2 602 788 887 | -3.3% | 37.2% | -2.5 | -5.7% |
| MIGRENIUM | |||||||||
| WoW | 9 058 | 7.6% | 0.4% | 0 | 3 162 500 | 7.8% | 0.5% | 0 | 8.0% |
| MoM | 41 128 | 0.4% | 0.4% | 0 | 14 076 174 | 0.9% | 0.6% | 0.1 | -9.7% |
| YTD | 567 845 | -11.5% | 0.5% | -0.1 | 181 651 511 | 48.1% | 0.6% | 0.2 | 3.9% |
| MAT | 567 845 | -11.5% | 0.5% | -0.1 | 181 651 511 | 48.1% | 0.6% | 0.2 | 3.9% |
| MODELAX-N | |||||||||
| WoW | 26 664 | 2.8% | 18.2% | 0.3 | 13 729 710 | 4.0% | 12.7% | 0.2 | 1.3% |
| MoM | 119 981 | 0.2% | 20.6% | 0.4 | 59 442 550 | 4.1% | 13.8% | 0.6 | -2.0% |
| YTD | 1 463 558 | 25.3% | 21.7% | 3.1 | 659 265 085 | 72.2% | 14.2% | 3.8 | 7.5% |
| MAT | 1 463 558 | 25.3% | 21.7% | 3.1 | 659 265 085 | 72.2% | 14.2% | 3.8 | 7.5% |
| REDUXIN | |||||||||
| WoW | 9 222 | 1.5% | 30.9% | -0.8 | 50 680 511 | 3.6% | 43.4% | -0.9 | 4.1% |
| MoM | 41 852 | -9.0% | 31.6% | -0.8 | 222 036 149 | -6.5% | 43.9% | -0.4 | -6.7% |
| YTD | 595 477 | -6.6% | 32.6% | -0.3 | 3 163 410 580 | 10.1% | 45.2% | 2.8 | -5.7% |
| MAT | 595 477 | -6.6% | 32.6% | -0.3 | 3 163 410 580 | 10.1% | 45.2% | 2.8 | -5.7% |
| REDUXIN FORTE | |||||||||
| WoW | 2 717 | -1.3% | 9.1% | -0.5 | 12 351 585 | 0.8% | 10.6% | -0.5 | 4.1% |
| MoM | 12 608 | -9.7% | 9.5% | -0.3 | 53 587 719 | -9.2% | 10.6% | -0.4 | -6.7% |
| YTD | 167 356 | 0.8% | 9.2% | 0.6 | 721 703 149 | 10.4% | 10.3% | 0.7 | -5.7% |
| MAT | 167 356 | 0.8% | 9.2% | 0.6 | 721 703 149 | 10.4% | 10.3% | 0.7 | -5.7% |
| SALVISAR | |||||||||
| WoW | 13 549 | 2.7% | 1.8% | 0 | 6 148 456 | 2.9% | 1.7% | 0 | 3.2% |
| MoM | 65 206 | 11.6% | 2.0% | 0.3 | 28 985 629 | 13.4% | 1.8% | 0.3 | -7.2% |
| YTD | 571 780 | 14.7% | 1.5% | 0.2 | 240 940 639 | 47.1% | 1.3% | 0.3 | -4.0% |
| MAT | 571 780 | 14.7% | 1.5% | 0.2 | 240 940 639 | 47.1% | 1.3% | 0.3 | -4.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 421 445 | 23.6% | 12.3% | 3.2 | 839 087 279 | 27.7% | 9.3% | 1.6 | -8.2% |
| BRAINMAX | 82 666 | 77.2% | 100.0% | 0 | 286 721 041 | 78.1% | 100.0% | 0 | 77.2% |
| GOLDLINE PLUS | 829 100 | -4.6% | 45.4% | 0.5 | 2 602 788 887 | -3.3% | 37.2% | -2.5 | -5.7% |
| MIGRENIUM | 567 845 | -11.5% | 0.5% | -0.1 | 181 651 511 | 48.1% | 0.6% | 0.2 | 3.9% |
| MODELAX-N | 1 463 558 | 25.3% | 21.7% | 3.1 | 659 265 085 | 72.2% | 14.2% | 3.8 | 7.5% |
| REDUXIN CAPS | 595 477 | -6.6% | 32.6% | -0.3 | 3 163 410 580 | 10.1% | 45.2% | 2.8 | -5.7% |
| REDUXIN FORTE | 167 356 | 0.8% | 9.2% | 0.6 | 721 703 149 | 10.4% | 10.3% | 0.7 | -5.7% |
| SALVISAR | 571 780 | 14.7% | 1.5% | 0.2 | 240 940 639 | 47.1% | 1.3% | 0.3 | -4.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 421 445 | 23.6% | 12.3% | 3.2 | 839 087 279 | 27.7% | 9.3% | 1.6 | -8.2% |
| BRAINMAX | 82 666 | 77.2% | 100.0% | 0 | 286 721 041 | 78.1% | 100.0% | 0 | 77.2% |
| GOLDLINE PLUS | 829 100 | -4.6% | 45.4% | 0.5 | 2 602 788 887 | -3.3% | 37.2% | -2.5 | -5.7% |
| MIGRENIUM | 567 845 | -11.5% | 0.5% | -0.1 | 181 651 511 | 48.1% | 0.6% | 0.2 | 3.9% |
| MODELAX-N | 1 463 558 | 25.3% | 21.7% | 3.1 | 659 265 085 | 72.2% | 14.2% | 3.8 | 7.5% |
| REDUXIN CAPS | 595 477 | -6.6% | 32.6% | -0.3 | 3 163 410 580 | 10.1% | 45.2% | 2.8 | -5.7% |
| REDUXIN FORTE | 167 356 | 0.8% | 9.2% | 0.6 | 721 703 149 | 10.4% | 10.3% | 0.7 | -5.7% |
| SALVISAR | 571 780 | 14.7% | 1.5% | 0.2 | 240 940 639 | 47.1% | 1.3% | 0.3 | -4.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 7 983 | -11.5% | 12.4% | -1.4 | 15 457 482 | -11.6% | 8.7% | -1.1 | -1.8% |
| BRAINMAX | 2 245 | -3.1% | 100.0% | 0 | 7 471 863 | -6.3% | 100.0% | 0 | -3.1% |
| GOLDLINE PLUS | 14 116 | 5.9% | 47.3% | 0.8 | 45 210 908 | 9.2% | 38.7% | 1.2 | 4.1% |
| MIGRENIUM | 9 058 | 7.6% | 0.4% | 0 | 3 162 500 | 7.8% | 0.5% | 0 | 8.0% |
| MODELAX-N | 26 664 | 2.8% | 18.2% | 0.3 | 13 729 710 | 4.0% | 12.7% | 0.2 | 1.3% |
| REDUXIN CAPS | 9 222 | 1.5% | 30.9% | -0.8 | 50 680 511 | 3.6% | 43.4% | -0.9 | 4.1% |
| REDUXIN FORTE | 2 717 | -1.3% | 9.1% | -0.5 | 12 351 585 | 0.8% | 10.6% | -0.5 | 4.1% |
| SALVISAR | 13 549 | 2.7% | 1.8% | 0 | 6 148 456 | 2.9% | 1.7% | 0 | 3.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 44 632 | -3.6% | 13.3% | -0.2 | 78 965 673 | 0.5% | 8.9% | 0.2 | -2.0% |
| BRAINMAX | 11 703 | 2.1% | 100.0% | 0 | 38 888 035 | -0.2% | 100.0% | 0 | 2.1% |
| GOLDLINE PLUS | 62 745 | -4.1% | 47.4% | 1.3 | 195 756 051 | -3.4% | 38.7% | 0.9 | -6.7% |
| MIGRENIUM | 41 128 | 0.4% | 0.4% | 0 | 14 076 174 | 0.9% | 0.6% | 0.1 | -9.7% |
| MODELAX-N | 119 981 | 0.2% | 20.6% | 0.4 | 59 442 550 | 4.1% | 13.8% | 0.6 | -2.0% |
| REDUXIN CAPS | 41 852 | -9.0% | 31.6% | -0.8 | 222 036 149 | -6.5% | 43.9% | -0.4 | -6.7% |
| REDUXIN FORTE | 12 608 | -9.7% | 9.5% | -0.3 | 53 587 719 | -9.2% | 10.6% | -0.4 | -6.7% |
| SALVISAR | 65 206 | 11.6% | 2.0% | 0.3 | 28 985 629 | 13.4% | 1.8% | 0.3 | -7.2% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
*****
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs